PFPT
TARO

Pinnacle Financial Partners (Tennessee)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed – – 602
2022
Q3 		$0 Buy
+5
New +$172 ﹤0.01% 560

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s TARO Position: Q4 2022 in Review

Pinnacle Financial Partners (Tennessee) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2022, closing a stake of 5 shares.

Pinnacle Financial Partners (Tennessee) first reported a position in TARO in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 62 funds tracked by Wall St. Rank hold TARO as of Q4 2022.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 5 Taro Pharmaceutical Industries Ltd. shares in Q4 2022.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2022 and held it in 1 quarter.
  • Pinnacle Financial Partners (Tennessee)'s Taro Pharmaceutical Industries Ltd. position peaked at $0 in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2022.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2022, filed 3 Feb 2023.